Home Latest Articles
Latest Articles
  • Huimin CAO, Haidong FANG, Yushan CHEN
    World Clinical Drug. 2024, 45(6): 636-641.
    Objective

    To explore the effect of roxadustat on renal anemia (RA) patients with low responsiveness to erythropoietic stimulant (ESA) receiving maintenance hemodialysis (MHD), and its effects on serum hemoglobin (Hb) compliance rate and folic acid (FA) level.

    Methods

    A total of 100 RA patients with low responsiveness to ESA receiving MHD in the department of nephrology in our hospital were selected and randomly divided into recombinant human erythropoietin (rhEPO) group and roxadustat group, 50 cases in each group. The two groups were treated continuously for 12 weeks, and the Hb compliance rate and serum FA level were compared between the two groups after treatment.

    Results

    At 4 and 12 weeks of treatment, the Hb compliance rate in roxadustat group was higher than that in rhEPO group (P<0.05). After treatment, serum Hb, FA, hematocrit, erythrocyte count and vitamin B12 levels in roxadustat group were higher than those in rhEPO group (P<0.05), serum ferritin, transferrin saturation and serum iron level in roxadustat group were lower than those in rhEPO group (P<0.05).

    Conclusion

    Roxadustat has significant efficacy in RA patients with low responsiveness to ESA receiving MHD, which can effectively improve anemia status, increase Hb compliance rate and serum FA level, improve iron metabolism, and has good safety.

  • Jiayuan WANG, Hua YANG, Tengfei WU, Yilei CONG, Bowen LIU
    World Clinical Drug. 2024, 45(6): 642-647.
    Objective

    To observe the effect of combination of Qiyu prescription and vitamin D on Hashimoto's thyroiditis (HT) of Qi deficiency and liver depression syndrome.

    Methods

    A total of 113 HT patients with Qi deficiency and liver depression syndrome in department of endocrinology of our hospital from March to December 2023 were included and randomly divided into traditional Chinese medicine (TCM) group (n=38, basic treatment+Qiyu prescription), TCM+vitamin D group (n=38, basic treatment+Qiyu prescription+alfacalcidol) and control group (n=37, basic treatment). All patients were treated for 12 weeks. Thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb), thyroid-stimulating hormone (TSH) levels and TCM syndrome scores of three groups were observed before and after treatment.

    Results

    The clinical effective rates of TCM group and TCM+vitamin D group were 78.95% and 84.21%, which were higher than control group (40.54%)(P<0.05). The titers of thyroid autoantibody in TCM group and TCM+vitamin D group were lower than before treatment (P<0.05), and the change rates of antibody were better than that in control group, and the change rates of TPOAb in TCM+vitamin D group were better than that in TCM group (P<0.05). TCM syndrome scores in TCM group and TCM+vitamin D group were lower than before treatment (P<0.05), and better than control group (P<0.05).

    Conclusion

    Combination of Qiyu prescription and vitamin D has a better effect on HT patients with Qi deficiency and liver depression syndrome, and can reduce serum TPOAb and TgAb levels, which is more effective on TPOAb compared to the use of TCM alone.

  • Sa PAN, Lei XIAO, Hua WANG
    World Clinical Drug. 2024, 45(6): 648-653.
    Objective

    To investigate the effects of combination of Wenshen Huatan Tiaojing prescription and conventional western medicine on reproductive hormone, glycolipid metabolism in patients with polycystic ovary syndrome (PCOS) of kidney deficiency phlegm-dampness.

    Methods

    A total of 96 PCOS patients of kidney deficiency and phlegm-dampness admitted to our hospital from January 2022 to January 2023 were randomly divided into observation group (ethoestradiol cyproterone+metformin+Wenshen Huatan Tiaojing prescription) and control group (ethoestradiol cyproterone+metformin) according to simple sort, with 48 cases in each group. The treatment lasted for 21 days and drug withdrawal for 7 days. Both groups were treated for 3 consecutive courses. The clinical efficacy, luteinizing hormone (LH), LH/follicular estrogen (FSH), anti-muller test tube hormone (AMH), inhibin (INH)B, glycosylated hemoglobin (Hb) A1c, total cholesterol (TC), triacylglycerol (TG) and homeostasis model assessment-insulin resistance (HOMA-IR) were compared between the two groups.

    Results

    The total effective rate of the observation group was higher than that of the control group (89.58% vs 62.50%, P<0.05). The levels of LH and LH/FSH in the observation group were lower than those in the control group (P<0.05). The levels of AMH, INHB, HbA1c, TC, TG and HOMA-IR in observation group were lower than those in control group (P<0.05). There was no significant difference in adverse reactions between the two groups (P>0.05).

    Conclusion

    Combination of Wenshen Huatan Tiaojing prescription and conventional western medicine has obvious effect on PCOS patients of kidney deficiency phlegm-dampness, which can help regulate reproductive hormone and glycolipid metabolism indexes.

  • Jian ZHAO, Juping BAI, Yunhua WEI, Yanbin GAO
    World Clinical Drug. 2024, 45(6): 654-657.
    Objective

    To observe the clinical effect of Jianpi Lishui Huazhuo prescription in the treatment of overweight or obesity complicated with hyperuricemia (HUA).

    Methods

    A total of 90 overweight or obese patients with HUA in the department of traditional Chinese medicine (TCM) of our hospital from October 2020 to June 2023 were selected and divided into treatment group and control group according to simple sort randomization, with 45 cases in each group. Both groups were given low fat, low purine diet and febuxosta, and the treatment group was given Jianpi Lishui Huazhuo prescription. The course of treatment in both groups was 12 weeks. The therapeutic effect, body mass index (BMI) and blood uric acid (UA) levels were compared between the two groups.

    Results

    After treatment, the total effective rate of TCM syndrome in the treatment group was higher than that in the control group (92.68% vs 65.12%, P<0.05). BMI and UA levels in the treatment group were lower than those in the control group (P<0.05).

    Conclusion

    Jianpi Lishui Huazhuo prescription is effective in overweight or obese patients with HUA, which is worthy of clinical promotion.

  • Zhaotang GONG, Wurihan, Siriguleng
    World Clinical Drug. 2024, 45(6): 658-664.

    Extracorporeal organ support (ECOS) plays a crucial role in rescuing critically ill patients, however, there are adverse events such as bleeding and thrombosis during treatment, so selecting appropriate anticoagulants is very important in ECOS therapy. This article reviewed the anticoagulant application of heparin, low molecular weight heparin, direct thrombin inhibitors, and citric acid in extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT), elucidated the current usage status of anticoagulant drugs in ECMO and CRRT, summarized their characteristics, contraindications and associated adverse reactions, in order to provide certain theoretical basis for deeply exploring alternative options to heparin in ECMO and selecting appropriate anticoagulant drugs for high-risk bleeding patients undergoing CRRT.

  • Juanjuan ZHANG, Hong LI, Weian MAO, Min CHEN
    World Clinical Drug. 2024, 45(6): 665-672.

    In recent years, the incidence of gout and hyperuricemia (HUA) has been increasing year by year worldwide, which seriously affects the normal life of patients and causes great pressure on the medical and health care system. Western medicine therapy for gout and HUA is effective, but drug-related adverse reactions are difficult to ignore. Traditional Chinese medicine has gradually attracted attention because of its diversified methods and high safety. In addition, changes in microbiota, novel xanthine oxidase inhibitory peptides, and genetic markers have made more achievements in the pathogenesis, intervention and treatment of gout and HUA. This article reviewed the latest progress in the treatment of gout and HUA in recent years to provide reference for clinical reference.

  • Jiayi CHEN, Jian SONG, Jiajian HE, Haohua XU, Huiqun LI, Encun HOU
    World Clinical Drug. 2024, 45(6): 673-677.

    Non-small cell lung cancer (NSCLC) is a common malignant tumor in clinical practice, many patients have developed to the middle and late stages once diagnosed, and have lost the opportunity of surgical treatment. Modern medicine often uses chemoradiotherapy, targeted drugs, immune checkpoint inhibitors and other comprehensive treatment methods, but there are different degrees of adverse reactions, so that the tolerance of patients is reduced, and the 5-year survival rate of patients is still low. In recent years, the combination of traditional Chinese medicine (TCM) and western medicine has obvious advantages in the treatment of middle and advanced NSCLC, in which TCM injection plays a significant role in reducing adverse reactions in the adjuvant treatment of NSCLC. This article reviewed the research and application status of TCM injection in the adjuvant treatment of NSCLC, in order to provide reference for clinical treatment and provide ideas for the development of new preparations of TCM.

  • Caiyun XIAO, Qiwei WANG, Yue LIU, Wen GUO
    World Clinical Drug. 2024, 45(6): 678-684.

    Based on the main nodes of the pharmaceutical supply chain, including raw material production, drug production, and healthcare institution procurement, a system dynamics model was established to investigate the variations in supply at each node under different patient demand conditions. Simulation of market demand models with transition function changes, periodic function changes, and stochastic function changes was conducted to analyze the different effects on the stability of the supply chain. It is recommended that supply chain planning should flexibly adjust strategies according to demand changes to ensure the stability of drug supply and meet patient demands.

  • Yiwen XU, Miao WANG, Xutao WANG, Hong SU
    World Clinical Drug. 2024, 45(6): 685-692.
    Objective

    To investigate the impact of the national centralized procurement policies (referred to as centralized procurement below) on the use of insulin in public hospitals.

    Methods

    Using descriptive statistical analysis and interrupted time series analysis, the national implementation of insulin centralized procurement was taken as the policy intervention point to analyze the changes in sales amount, sales volume, and average daily usage cost of insulin in sample hospitals before and after the centralized procurement from 2017 Q1 (each year is divided into four quarters, which are commonly referred to as Q1, Q2, Q3, and Q4, respectively) to 2023 Q3.

    Results

    After centralized procurement, the sales trend of different types of insulin changed differently, with second-generation and foreign-funded brand insulin showing a downward trend, and third-generation and domestic brand insulin showing an upward trend. The sales amount of different types of insulin decreased, and the average daily use cost had obvious breakpoints and decreased significantly.

    Conclusion

    Centralized procurement effectively controlled the costs of insulin, promoted the iteration of insulin use, altered the brand usage landscape, and significantly reduced the drug burden of patients.

  • Lu YANG, Qingmei ZOU
    World Clinical Drug. 2024, 45(5): 449-453.

    Glucocorticoid (GC) has been widely used to treat inflammatory diseases, with significant therapeutic effects, but accompanied by a series of adverse reactions, including immunosuppression, osteoporosis, hyperglycemia, hypertension, cognitive problems, and digestive system diseases. By regularly monitoring the patients' physiological indicators and symptoms, the dosage of GC can be dynamically adjusted. Rational dietary management, bone density monitoring, and blood pressure monitoring are also key components to prevent adverse reactions. Alternative therapy can reduce patients' dependence on GC. Gene analysis and personalized therapy are expected to further optimize the efficacy of GC. This article reviewed the common adverse reactions of GC in clinical practice, explored prevention strategies through in-depth understanding of its mechanisms, to maximize the safety and efficacy of medication.

News